jetcityimage/iStock Editorial via Getty Images Eli Lilly ( NYSE: LLY ) has named Gordon Brooks as its interim chief financial officer, effective July 15, 2024. Brooks has held various leadership roles during his 29-year career with the company, and currently serves as group VP, controller and corporate strategy. He will replace Anat Ashkenazi, who stepped down from her roles of executive vice president and chief financial officer on June 5.
Ms. Ashkenazi will remain at the company through the end of July 2024 to facilitate the transition of her responsibilities, after which she will join Google’s parent company Alphabet ( GOOG ) ( GOOGL ) as its CFO. More on Eli Lilly What Eli Lilly Is Getting With The Acquisition Of Morphic Holding Wall Street Lunch: Merger Monday In All Its Glory Eli Lilly Targets IBD, Takes Calculated Gamble With $3.
2bn Morphic Deal Study finds patients lost more weight on Mounjaro than Ozempic Eli Lilly to acquire Morphic for $57 a share in cash.